A multidisciplinary perspective on the subcutaneous administration of trastuzumab in HER2-positive breast cancer.

Autor: Dent, S.1 susan.dent@duke.edu, Ammendolea, C.2, Christofides, A.3, Edwards, S.4, Incekol, D.5, Pourmirza, B.6, Kfoury, S.6, Poirier, B.7
Zdroj: Current Oncology. Feb2019, Vol. 26 Issue 1, pe70-e80. 11p.
Databáze: Academic Search Ultimate